$HBIO
HARVARD BIOSCIENCE INC

2013 Q4 Form 10-K Financial Statement

#000117184315001376 Filed on March 12, 2015

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2013 Q2
Revenue $27.85M $25.14M $26.09M
YoY Change -1.4% -3.7% -8.43%
Cost Of Revenue $15.81M $13.84M $14.01M
YoY Change 6.39% -2.1% -6.01%
Gross Profit $12.05M $11.30M $12.09M
YoY Change -10.04% -5.6% -11.08%
Gross Profit Margin 43.25% 44.95% 46.33%
Selling, General & Admin $7.480M $8.820M $8.752M
YoY Change -10.2% -7.18% -9.26%
% of Gross Profit 62.08% 78.06% 72.4%
Research & Development -$1.700M $1.934M $922.0K
YoY Change 40.5% 3.92% -53.25%
% of Gross Profit -14.11% 17.12% 7.63%
Depreciation & Amortization $960.0K $960.0K $1.000M
YoY Change -10.28% -5.88% -4.76%
% of Gross Profit 7.97% 8.5% 8.27%
Operating Expenses $13.00M $10.89M $11.34M
YoY Change 15.48% 0.67% 2.0%
Operating Profit -$949.0K $414.0K $746.0K
YoY Change -144.39% -64.19% -69.85%
Interest Expense -$360.0K $276.0K $245.0K
YoY Change 125.0% 87.76% 61.18%
% of Operating Profit 66.67% 32.84%
Other Income/Expense, Net -$319.0K -$358.0K -$330.0K
YoY Change 114.09% 101.12% 46.02%
Pretax Income -$1.268M $56.00K $416.0K
YoY Change -163.75% -94.27% -81.49%
Income Tax -$1.013M $105.0K $321.0K
% Of Pretax Income 187.5% 77.16%
Net Earnings -$756.0K -$984.0K -$186.0K
YoY Change -163.0% 639.85% -124.03%
Net Earnings / Revenue -2.71% -3.91% -0.71%
Basic Earnings Per Share -$0.02 -$0.03 -$0.01
Diluted Earnings Per Share -$0.02 -$0.03 -$0.01
COMMON SHARES
Basic Shares Outstanding 30.57M shares 30.10M shares
Diluted Shares Outstanding 30.57M shares 31.70M shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.80M $36.90M $34.10M
YoY Change 24.64% 81.77% 82.35%
Cash & Equivalents $25.77M $36.90M $36.93M
Short-Term Investments
Other Short-Term Assets $3.771M $1.600M $1.500M
YoY Change -18.36% -46.6% -48.4%
Inventory $15.78M $18.00M $18.30M
Prepaid Expenses
Receivables $13.88M $13.40M $13.80M
Other Receivables $3.800M $4.000M $5.100M
Total Short-Term Assets $60.75M $73.90M $72.80M
YoY Change 3.01% 25.76% 24.86%
LONG-TERM ASSETS
Property, Plant & Equipment $4.375M $4.600M $4.400M
YoY Change -3.87% 12.28% 16.46%
Goodwill $36.61M
YoY Change 1.12%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $316.0K $12.80M $12.40M
YoY Change -35.51% 19004.48% 11172.73%
Total Long-Term Assets $74.71M $74.40M $73.20M
YoY Change 0.27% 3.6% 2.77%
TOTAL ASSETS
Total Short-Term Assets $60.75M $73.90M $72.80M
Total Long-Term Assets $74.71M $74.40M $73.20M
Total Assets $135.5M $148.3M $146.0M
YoY Change 1.48% 13.57% 12.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.682M $4.700M $4.900M
YoY Change 0.04% 13.5% 6.36%
Accrued Expenses $5.078M $4.400M $3.800M
YoY Change 44.88% 16.83% 23.02%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $5.000M $3.000M $3.000M
YoY Change
Total Short-Term Liabilities $16.09M $13.50M $13.30M
YoY Change 62.46% 41.64% 34.17%
LONG-TERM LIABILITIES
Long-Term Debt $19.75M $20.50M $21.30M
YoY Change 52.51% 33.99% 32.3%
Other Long-Term Liabilities $5.000M $6.200M $5.800M
YoY Change -18.03% 26.53% 20.83%
Total Long-Term Liabilities $19.75M $26.70M $27.10M
YoY Change 52.51% 74.51% 68.32%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.09M $13.50M $13.30M
Total Long-Term Liabilities $19.75M $26.70M $27.10M
Total Liabilities $40.98M $40.50M $40.70M
YoY Change 39.98% 34.03% 29.14%
SHAREHOLDERS EQUITY
Retained Earnings -$95.04M
YoY Change 23.01%
Common Stock $202.8M $382.0K
YoY Change 2.96% -99.8%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 7.746M shares 7.746M shares
Shareholders Equity $94.49M $107.8M $105.4M
YoY Change
Total Liabilities & Shareholders Equity $135.5M $148.3M $146.0M
YoY Change 1.48% 13.57% 12.71%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2013 Q2
OPERATING ACTIVITIES
Net Income -$756.0K -$984.0K -$186.0K
YoY Change -163.0% 639.85% -124.03%
Depreciation, Depletion And Amortization $960.0K $960.0K $1.000M
YoY Change -10.28% -5.88% -4.76%
Cash From Operating Activities $1.250M $1.430M $800.0K
YoY Change -10.71% -43.03% -68.5%
INVESTING ACTIVITIES
Capital Expenditures -$530.0K -$510.0K -$290.0K
YoY Change -22.06% -5.56% -6.45%
Acquisitions
YoY Change
Other Investing Activities $70.00K $1.780M $0.00
YoY Change -450.0% 5833.33% -100.0%
Cash From Investing Activities -$460.0K $1.270M -$290.0K
YoY Change -34.29% -349.02% -63.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -12.48M -750.0K 9.700M
YoY Change 2300.0% 1.35% -1801.75%
NET CHANGE
Cash From Operating Activities 1.250M 1.430M 800.0K
Cash From Investing Activities -460.0K 1.270M -290.0K
Cash From Financing Activities -12.48M -750.0K 9.700M
Net Change In Cash -11.69M 1.950M 10.21M
YoY Change -6594.44% 54.76% 772.65%
FREE CASH FLOW
Cash From Operating Activities $1.250M $1.430M $800.0K
Capital Expenditures -$530.0K -$510.0K -$290.0K
Free Cash Flow $1.780M $1.940M $1.090M
YoY Change -14.42% -36.39% -61.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
7745507 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q3 us-gaap Revenues
Revenues
25448000 USD
CY2014Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14006000 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
11442000 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
10017000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1425000 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-469000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
956000 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
323000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
633000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
633000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.02
CY2014Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2014Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.02
CY2014Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
105000 USD
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2013Q3 us-gaap Revenues
Revenues
25137000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
414000 USD
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-358000 USD
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-984000 USD
CY2014 dei Document Type
DocumentType
10-K
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0001123494
CY2014 dei Entity Registrant Name
EntityRegistrantName
HARVARD BIOSCIENCE INC
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6263112 shares
CY2014Q4 hbio Total Indefinite Lived Intangible Assets Including Goodwill
TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill
41074000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-49000 USD
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.03
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.03
CY2013Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0
CY2013Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
56000 USD
CY2013Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13838000 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
11299000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
10885000 USD
CY2014Q4 hbio Total Intangible Assets
TotalIntangibleAssets
86712000 USD
CY2014 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
4691000 USD
CY2014 us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
-1474000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2000000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2100000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2300000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2500000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2600000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18820000 USD
CY2013Q4 hbio Date Separation Plan Completed
DateSeparationPlanCompleted
November 1, 2013
CY2013Q4 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2013-10-21
CY2013Q4 hbio Spinoff Distribution Ratio
SpinoffDistributionRatio
1 for 4
CY2013Q4 hbio Date Entered Into Commerical Agreements With Spinnee
DateEnteredIntoCommericalAgreementsWithSpinnee
31-Oct-13
CY2013Q4 hbio Lost Value Adjustment To Share And Exercise Price Of Existing Options
LostValueAdjustmentToShareAndExercisePriceOfExistingOptions
0.8 pure
CY2013Q4 hbio Percent Lost Value Provided Back To Option Holder
PercentLostValueProvidedBackToOptionHolder
0.2 pure
CY2013Q4 hbio Lost Value Adjustment To Share Amount Of Existing Outstanding Restricted Stock Units
LostValueAdjustmentToShareAmountOfExistingOutstandingRestrictedStockUnits
0.8 pure
CY2013Q4 hbio Percent Lost Value Provided Back To Restricted Stock Unit Holder
PercentLostValueProvidedBackToRestrictedStockUnitHolder
0.2 pure
CY2013Q4 hbio Asset Transfer As Part Of Spinoff
AssetTransferAsPartOfSpinoff
900000 USD
CY2013Q1 hbio Date Private Letter Ruling
DatePrivateLetterRuling
22-Mar-13
CY2013Q2 hbio Date Supplemental Ruling To Private Letter Ruling
DateSupplementalRulingToPrivateLetterRuling
28-Jun-13
CY2013Q4 hbio Taxable Spinoff From Percent Acquired Stock
TaxableSpinoffFromPercentAcquiredStock
0.5 pure
CY2013Q4 hbio Transfer Of Cash And Cash Equivalents To Hart
TransferOfCashAndCashEquivalentsToHART
15000000 USD
CY2013Q4 hbio Incremental Options Granted Due To Hart Spinoff
IncrementalOptionsGrantedDueToHartSpinoff
1700000 shares
CY2013Q4 hbio Incremental Units Granted Due To Hart Spinoff
IncrementalUnitsGrantedDueToHartSpinoff
100000 shares
CY2013 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
-179000 USD
CY2013 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
262000 USD
CY2013Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
305000 USD
CY2014 hbio Service Cost For Defined Benefit Plan
ServiceCostForDefinedBenefitPlan
0 USD
CY2013 us-gaap Defined Benefit Plan Actual Return On Plan Assets
DefinedBenefitPlanActualReturnOnPlanAssets
1125000 USD
CY2013 us-gaap Defined Benefit Plan Foreign Currency Exchange Rate Changes Plan Assets
DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets
285000 USD
CY2014 us-gaap Defined Benefit Plan Foreign Currency Exchange Rate Changes Plan Assets
DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets
-1029000 USD
CY2013Q4 us-gaap Defined Benefit Plan Funded Status Of Plan
DefinedBenefitPlanFundedStatusOfPlan
-4863000 USD
CY2013Q4 us-gaap Defined Benefit Plan Amounts Recognized In Balance Sheet
DefinedBenefitPlanAmountsRecognizedInBalanceSheet
-3878000 USD
CY2013Q4 hbio Deferred Income Taxes On Pension Liabilities
DeferredIncomeTaxesOnPensionLiabilities
985000 USD
CY2013Q4 us-gaap Defined Benefit Pension Plan Current And Noncurrent Liabilities
DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities
4863000 USD
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3557000 USD
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3878000 USD
CY2014 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
0.0443 pure
CY2013 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
0.0443 pure
CY2012 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
0.0409 pure
CY2012 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
0.0402 pure
CY2013 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
0.0379 pure
CY2014 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
0.0415 pure
CY2014 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
0 pure
CY2013 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
0.0299 pure
CY2012 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
0.0351 pure
CY2014 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate Support Methodology And Source Data
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRateSupportMethodologyAndSourceData
The discount rate assumptions used for pension accounting reflect the prevailing rates available on high-quality, fixed-income debt instruments with terms that match the average expected duration of the Company’s defined benefit pension plan obligations. The Company uses the iBoxx AA 15yr+ index, which matches the average duration of its pension plan liability of approximately 15 years. With the current base of assets in the pension plans, a 0.1% increase/decrease in the discount rate assumption would decrease/increase annual pension expense by approximately $##D<pen-disc-rate-change>.
CY2014Q4 us-gaap Defined Benefit Plan Weighted Average Asset Allocations
DefinedBenefitPlanWeightedAverageAssetAllocations
1 pure
CY2013Q4 us-gaap Defined Benefit Plan Weighted Average Asset Allocations
DefinedBenefitPlanWeightedAverageAssetAllocations
1 pure
CY2014 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2024-08-31
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1115300 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.18
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
-847860 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
4.67
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6690845 shares
CY2013Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
3.42
CY2014Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
3.42
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
306397 shares
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.08
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
463973 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
-233098 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.32
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.3
CY2014 hbio Stock Issued During Period Gross Stock Options Exercised
StockIssuedDuringPeriodGrossStockOptionsExercised
695173 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
-40878 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
4.36
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
116400 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.12
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5578 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.018 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M3D
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5718 pure
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5509 pure
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.008 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0142 pure
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y8M1D
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y11M23D
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
2670000 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
2156000 USD
CY2014Q4 hbio Percentage Of Outstanding Common Stock
PercentageOfOutstandingCommonStock
0.2 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Offering Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate
0.85 pure
CY2014Q4 hbio Employee Stock Purchase Plan Shares Authorized
EmployeeStockPurchasePlanSharesAuthorized
750000 shares
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
585188 shares
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2526441 shares
CY2014Q4 us-gaap Secured Debt
SecuredDebt
24750000 USD
CY2014Q4 hbio Lender Approval To Fund Acquisition With Cash Promissory Note In Excess Of Threshold
LenderApprovalToFundAcquisitionWithCashPromissoryNoteInExcessOfThreshold
6000000 USD
CY2014Q4 hbio Lender Approval To Fund Acquisition With Equity In Excess Of Threshold
LenderApprovalToFundAcquisitionWithEquityInExcessOfThreshold
10000000 USD
CY2009Q3 hbio Previous Approved Credit Facility
PreviousApprovedCreditFacility
20000000 USD
CY2013Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
50000000 USD
CY2013Q1 hbio Ddtl Threshold For Dollar For Dollar Reduction In Revolving Line
DdtlThresholdForDollarForDollarReductionInRevolvingLine
10000000 USD
CY2009Q3 hbio Interest Rate In Excess Of Libor On Credit Facility
InterestRateInExcessOfLiborOnCreditFacility
0.03 pure
CY2014Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
11800000 USD
CY2013Q4 hbio Transferof Delayed Draw Down Term Loan Capacity To Revolver Capacity
TransferofDelayedDrawDownTermLoanCapacityToRevolverCapacity
5000000 USD
CY2014Q4 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
13500000 USD
CY2014 us-gaap Derivative Instruments Loss Recognized In Other Comprehensive Income Effective Portion
DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion
-99000 USD
CY2014 us-gaap Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion
DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
-130000 USD
CY2014 us-gaap Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimated Net Amount To Be Transferred
DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
100000 USD
CY2014 hbio Derivative Interest Rate Swap Effective Percentage
DerivativeInterestRateSwapEffectivePercentage
1 pure
CY2013 hbio Distribution Revenues From Spinnee
DistributionRevenuesFromSpinnee
100000 USD
CY2014 hbio Distribution Revenues From Spinnee
DistributionRevenuesFromSpinnee
200000 USD
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-12-31
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-14
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
191000 USD
CY2014 us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
2
CY2014 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
-67000 USD
CY2013 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
172000 USD
CY2013 us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
-8000 USD
CY2014 us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
56000 USD
CY2014Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
328000 USD
CY2013Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
358000 USD
CY2014 us-gaap Discontinued Operation Amount Of Other Income Loss From Disposition Of Discontinued Operation Net Of Tax
DiscontinuedOperationAmountOfOtherIncomeLossFromDispositionOfDiscontinuedOperationNetOfTax
0 USD
CY2012Q2 us-gaap Discontinued Operation Amount Of Other Income Loss From Disposition Of Discontinued Operation Net Of Tax
DiscontinuedOperationAmountOfOtherIncomeLossFromDispositionOfDiscontinuedOperationNetOfTax
-281000 USD
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33164780 shares
CY2013 us-gaap Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
26000 USD
CY2014 us-gaap Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
200000 USD
CY2013 hbio Transition Services Charged To Spinnee
TransitionServicesChargedToSpinnee
100000 USD
CY2014 hbio Transition Services Charged To Spinnee
TransitionServicesChargedToSpinnee
100000 USD
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5589000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4375000 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20200000 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15010000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13884000 USD
CY2013Q4 us-gaap Assets
Assets
135460000 USD
CY2013Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1289000 USD
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3771000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
15777000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
13116000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
19009000 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
358000 USD
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39384974 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31639467 shares
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
7745507 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1547000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
60750000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
316000 USD
CY2013Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
5000000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4682000 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
640000 USD
CY2013Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
99000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5078000 USD
CY2013Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
586000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16085000 USD
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
19750000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
160000 USD
CY2013Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
4980000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
40975000 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
390000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
202446000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-95039000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2644000 USD
CY2013Q4 us-gaap Treasury Stock Carrying Basis
TreasuryStockCarryingBasis
10668000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
135460000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16141000 USD
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1515000 USD
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4742000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
57063000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5190000 USD
CY2014Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
11056000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
21153000 USD
CY2014Q4 us-gaap Goodwill
Goodwill
39822000 USD
CY2014Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1252000 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
380000 USD
CY2014Q4 us-gaap Assets
Assets
135916000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
20531000 USD
CY2014Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
5000000 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6294000 USD
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
655000 USD
CY2014Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
554000 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4452000 USD
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
328000 USD
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40308763 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32563256 shares
CY2014Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1023000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18099000 USD
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
16450000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1325000 USD
CY2014Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
4574000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
40448000 USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
397000 USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
206656000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-92684000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8233000 USD
CY2014Q4 us-gaap Treasury Stock Carrying Basis
TreasuryStockCarryingBasis
10668000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
135916000 USD
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0pt;' >(b)</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0pt;' >Use of Estimates</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:27pt;' >The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires the use of management estimates. Such estimates include the det</font><font style='font-family:Times New Roman;font-size:10pt;' >ermination and establishment of certain accruals and provisions, including those for inventory obsolescence, catalog cost amortization periods, income tax and reserves for bad debts. In addition, certain estimates are required in order to determine the val</font><font style='font-family:Times New Roman;font-size:10pt;' >ue of assets and liabilities associated with acquisitions. Estimates are also required to evaluate the value and recoverability of existing long-lived and intangible assets, including goodwill. On an ongoing basis, the Company reviews its estimates based u</font><font style='font-family:Times New Roman;font-size:10pt;' >pon currently available information. Actual results could differ materially from those estimates.</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ></p></div>
CY2012 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
58831000 USD
CY2012 us-gaap Gross Profit
GrossProfit
52340000 USD
CY2012 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
18287000 USD
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18121000 USD
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4344000 USD
CY2012 us-gaap Other General Expense
OtherGeneralExpense
696000 USD
CY2012 us-gaap Restructuring Charges
RestructuringCharges
310000 USD
CY2012 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
0 USD
CY2014 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0pt;' >(s)</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0pt;' >Recently Issued Accounting Pronouncements</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >&#8220;Revenue from Contracts with </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >Customers,&#8221;</font><font style='font-family:Times New Roman;font-size:10pt;' > a new accounting standard that provides for a comprehensive model to use in the accounting for revenue arising from contracts with customers that will replace most existing revenue recognition guidance in U.S. GAAP. Under this standard, revenue</font><font style='font-family:Times New Roman;font-size:10pt;' > will be recognized to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. This standard will be effective as of th</font><font style='font-family:Times New Roman;font-size:10pt;' >e beginning of the Company&#8217;s 2017 fiscal year. The Company is assessing the new standard and has not yet determined the impact to the consolidated financial statements.</font></p></div>
CY2012 us-gaap Operating Expenses
OperatingExpenses
44510000 USD
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
7830000 USD
CY2012 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-113000 USD
CY2012 us-gaap Revenues
Revenues
111171000 USD
CY2012 us-gaap Interest Expense
InterestExpense
584000 USD
CY2012 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
46000 USD
CY2012 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-287000 USD
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-938000 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
6892000 USD
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2398000 USD
CY2012 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
4494000 USD
CY2012 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-2124000 USD
CY2012 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.15
CY2012 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.07
CY2012 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2013 us-gaap Revenues
Revenues
105171000 USD
CY2013 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
57475000 USD
CY2013 us-gaap Gross Profit
GrossProfit
47696000 USD
CY2013 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17330000 USD
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17887000 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4154000 USD
CY2014 us-gaap Revenues
Revenues
108663000 USD
CY2014 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
59319000 USD
CY2014 us-gaap Gross Profit
GrossProfit
49344000 USD
CY2014 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
18225000 USD
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16826000 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4880000 USD
CY2013 us-gaap Other General Expense
OtherGeneralExpense
2048000 USD
CY2014 us-gaap Other General Expense
OtherGeneralExpense
0 USD
CY2013 us-gaap Restructuring Charges
RestructuringCharges
2150000 USD
CY2014 us-gaap Restructuring Charges
RestructuringCharges
1027000 USD
CY2013 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
0 USD
CY2014 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
810000 USD
CY2013 us-gaap Operating Expenses
OperatingExpenses
46159000 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
1537000 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
42726000 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
6618000 USD
CY2013 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-139000 USD
CY2013 us-gaap Interest Expense
InterestExpense
955000 USD
CY2013 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
43000 USD
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-51000 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1102000 USD
CY2014 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-150000 USD
CY2014 us-gaap Interest Expense
InterestExpense
990000 USD
CY2014 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
74000 USD
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1135000 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2201000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
435000 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-288000 USD
CY2013 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
723000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4417000 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2062000 USD
CY2014 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
2355000 USD
CY2013 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-2553000 USD
CY2014 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
CY2013 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.02
CY2013 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.08
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2013 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.02
CY2013 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.08
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2014 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.07
CY2014 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2014 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2014 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.07
CY2014 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2014 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2012 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.16
CY2012 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.07
CY2012 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2014 us-gaap Net Income Loss
NetIncomeLoss
2355000 USD
CY2014 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
2156000 USD
CY2012 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
3321000 USD
CY2014 us-gaap Depreciation
Depreciation
1253000 USD
CY2013 us-gaap Depreciation
Depreciation
1298000 USD
CY2012 us-gaap Depreciation
Depreciation
1270000 USD
CY2014 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
0 USD
CY2013 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
440000 USD
CY2012 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
1344000 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
2370000 USD
CY2014 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
810000 USD
CY2013 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 USD
CY2012 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
24000 USD
CY2014 hbio Non Cash Restructuring Charge
NonCashRestructuringCharge
-120000 USD
CY2013 hbio Non Cash Restructuring Charge
NonCashRestructuringCharge
-46000 USD
CY2012 hbio Non Cash Restructuring Charge
NonCashRestructuringCharge
-13000 USD
CY2014 hbio Amortization Of Catalog Costs
AmortizationOfCatalogCosts
47000 USD
CY2013 hbio Amortization Of Catalog Costs
AmortizationOfCatalogCosts
101000 USD
CY2012 hbio Amortization Of Catalog Costs
AmortizationOfCatalogCosts
184000 USD
CY2014 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-67000 USD
CY2013 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
172000 USD
CY2012 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-31000 USD
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2578000 USD
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2590000 USD
CY2012 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2752000 USD
CY2014 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
61000 USD
CY2013 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
46000 USD
CY2012 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
52000 USD
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1412000 USD
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2441000 USD
CY2012 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-731000 USD
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
735000 USD
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-436000 USD
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1154000 USD
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3056000 USD
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1921000 USD
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1174000 USD
CY2014 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
370000 USD
CY2013 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1020000 USD
CY2012 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
925000 USD
CY2014 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1069000 USD
CY2013 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-41000 USD
CY2012 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-905000 USD
CY2014 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-269000 USD
CY2013 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
323000 USD
CY2012 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
213000 USD
CY2014 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-345000 USD
CY2013 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
847000 USD
CY2012 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-485000 USD
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
28000 USD
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
146000 USD
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-48000 USD
CY2014 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-836000 USD
CY2013 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-672000 USD
CY2012 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
78000 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4351000 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4060000 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8062000 USD
CY2014 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
-2005000 USD
CY2013 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
-1622000 USD
CY2012 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
-1769000 USD
CY2014 hbio Additions To Catalog Costs
AdditionsToCatalogCosts
0 USD
CY2013 hbio Additions To Catalog Costs
AdditionsToCatalogCosts
-57000 USD
CY2012 hbio Additions To Catalog Costs
AdditionsToCatalogCosts
-62000 USD
CY2014 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1141000 USD
CY2013 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
66000 USD
CY2012 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
33000 USD
CY2014 hbio Proceeds From Sale Of Discontinued Operations
ProceedsFromSaleOfDiscontinuedOperations
0 USD
CY2013 hbio Proceeds From Sale Of Discontinued Operations
ProceedsFromSaleOfDiscontinuedOperations
1784000 USD
CY2012 hbio Proceeds From Sale Of Discontinued Operations
ProceedsFromSaleOfDiscontinuedOperations
0 USD
CY2014 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
12653000 USD
CY2013 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2012 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2878000 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13517000 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
171000 USD
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4676000 USD
CY2014 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5500000 USD
CY2013 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2750000 USD
CY2012 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3850000 USD
CY2014 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
2200000 USD
CY2013 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
14550000 USD
CY2012 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
500000 USD
CY2014 hbio Transfer Of Cash And Cash Equivalents To Hart
TransferOfCashAndCashEquivalentsToHART
0 USD
CY2013 hbio Transfer Of Cash And Cash Equivalents To Hart
TransferOfCashAndCashEquivalentsToHART
15041000 USD
CY2012 hbio Transfer Of Cash And Cash Equivalents To Hart
TransferOfCashAndCashEquivalentsToHART
0 USD
CY2014 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2013 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
312000 USD
CY2012 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2066000 USD
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3621000 USD
CY2012 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2287000 USD
CY2013Q4 us-gaap Secured Debt
SecuredDebt
24750000 USD
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
5000000 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1234000 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
68000 USD
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1063000 USD
CY2014 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1237000 USD
CY2013 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
791000 USD
CY2012 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
442000 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-11637000 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5090000 USD
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2765000 USD
CY2014 us-gaap Interest Paid
InterestPaid
997000 USD
CY2013 us-gaap Interest Paid
InterestPaid
892000 USD
CY2012 us-gaap Interest Paid
InterestPaid
577000 USD
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
843000 USD
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
1479000 USD
CY2012 us-gaap Income Taxes Paid
IncomeTaxesPaid
1519000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17916000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20681000 USD
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4051000 USD
CY2013 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
194000 USD
CY2013 hbio Shares Withheld For Taxes Value
SharesWithheldForTaxesValue
1083000 USD
CY2013 us-gaap Stockholders Equity Note Spinoff Transaction
StockholdersEquityNoteSpinoffTransaction
-15949000 USD
CY2013 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
2670000 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-1830000 USD
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2135000 shares
CY2013 us-gaap Stockholders Equity Other Shares
StockholdersEquityOtherShares
282000 shares
CY2013 hbio Shares Withheld For Taxes
SharesWithheldForTaxes
213000 shares
CY2014 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-5941000 USD
CY2013 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
1573000 USD
CY2012 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
1863000 USD
CY2014 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-99000 USD
CY2013 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-116000 USD
CY2012 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
0 USD
CY2014 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-130000 USD
CY2013 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-67000 USD
CY2012 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
0 USD
CY2014 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
31000 USD
CY2013 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-49000 USD
CY2012 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
0 USD
CY2014 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-207000 USD
CY2013 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-243000 USD
CY2012 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-191000 USD
CY2014 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-114000 USD
CY2013 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-452000 USD
CY2012 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
1195000 USD
CY2014 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-321000 USD
CY2013 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-695000 USD
CY2012 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
1004000 USD
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2219000 USD
CY2012 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
859000 USD
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3234000 USD
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
389000 USD
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3229000 USD
CY2014 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
52000 USD
CY2013 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
62000 USD
CY2012 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
57000 USD
CY2014 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
29000 USD
CY2013 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
115000 USD
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
9200000 USD
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
5000000 USD
CY2013 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
CY2013 us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
405000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
36200000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
36605000 USD
CY2012 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
-357000 USD
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
10138000 USD
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7039000 USD
CY2014Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
946000 USD
CY2013Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
752000 USD
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
9447000 USD
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
7986000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14445000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
45638000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-24485000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
41740000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-22731000 USD
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
735000 USD
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
927000 USD
CY2014Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
626000 USD
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
2250000 USD
CY2013Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
1434000 USD
CY2014Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
240000 USD
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
0 USD
CY2014Q4 us-gaap Long Term Debt
LongTermDebt
21450000 USD
CY2014Q4 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
83000 sqft
CY2014Q4 hbio Expansion Area Of Real Estate Property
ExpansionAreaOfRealEstateProperty
22000 sqft
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
2094000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1603000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1579000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1550000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1353000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
5867000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
14046000 USD
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1616000 USD
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1349000 USD
CY2013Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
305000 USD
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1235000 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1063000 USD
CY2014Q4 hbio Total Accrued Expenses
TotalAccruedExpenses
4452000 USD
CY2013Q4 hbio Total Accrued Expenses
TotalAccruedExpenses
5078000 USD
CY2014 hbio Current Federal And State Income Tax Expense Benefit Continuing Operations
CurrentFederalAndStateIncomeTaxExpenseBenefitContinuingOperations
27000 USD
CY2013 hbio Current Federal And State Income Tax Expense Benefit Continuing Operations
CurrentFederalAndStateIncomeTaxExpenseBenefitContinuingOperations
47000 USD
CY2012 hbio Current Federal And State Income Tax Expense Benefit Continuing Operations
CurrentFederalAndStateIncomeTaxExpenseBenefitContinuingOperations
70000 USD
CY2014 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
424000 USD
CY2013 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
413000 USD
CY2012 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
1705000 USD
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
451000 USD
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
460000 USD
CY2012 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1775000 USD
CY2014 hbio Deferred Federal And State Income Tax Expense Benefit Continuing Operations
DeferredFederalAndStateIncomeTaxExpenseBenefitContinuingOperations
1793000 USD
CY2013 hbio Deferred Federal And State Income Tax Expense Benefit Continuing Operations
DeferredFederalAndStateIncomeTaxExpenseBenefitContinuingOperations
-594000 USD
CY2012 hbio Deferred Federal And State Income Tax Expense Benefit Continuing Operations
DeferredFederalAndStateIncomeTaxExpenseBenefitContinuingOperations
931000 USD
CY2014 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-182000 USD
CY2013 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-154000 USD
CY2012 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-308000 USD
CY2014 hbio Deferred Income Taxes Amount
DeferredIncomeTaxesAmount
1611000 USD
CY2013 hbio Deferred Income Taxes Amount
DeferredIncomeTaxesAmount
-748000 USD
CY2012 hbio Deferred Income Taxes Amount
DeferredIncomeTaxesAmount
623000 USD
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1503000 USD
CY2013 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
147000 USD
CY2012 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
2343000 USD
CY2014 hbio Net Change In Income Tax Expense Benefit Resulting From Permanent Differences
NetChangeInIncomeTaxExpenseBenefitResultingFromPermanentDifferences
-93000 USD
CY2013 hbio Net Change In Income Tax Expense Benefit Resulting From Permanent Differences
NetChangeInIncomeTaxExpenseBenefitResultingFromPermanentDifferences
482000 USD
CY2012 hbio Net Change In Income Tax Expense Benefit Resulting From Permanent Differences
NetChangeInIncomeTaxExpenseBenefitResultingFromPermanentDifferences
-25000 USD
CY2014 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-364000 USD
CY2013 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-64000 USD
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2014Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2012 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-435000 USD
CY2014 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
0 USD
CY2013 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
31000 USD
CY2012 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
135000 USD
CY2014 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
67000 USD
CY2013 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
1000 USD
CY2012 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
254000 USD
CY2014 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
0 USD
CY2013 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-294000 USD
CY2012 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
0 USD
CY2014 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
-385000 USD
CY2013 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
-615000 USD
CY2012 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
-127000 USD
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1346000 USD
CY2013 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
31000 USD
CY2012 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
281000 USD
CY2014 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-12000 USD
CY2012Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
222000 USD
CY2014Q1 us-gaap Gross Profit
GrossProfit
11761000 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
248000 USD
CY2013 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-7000 USD
CY2012 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-28000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
1846000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-2549000 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
681000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
2571000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
2984000 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
6211000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
65000 USD
CY2013Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
1405000 USD
CY2013Q4 hbio Deferred Tax Assets Operating Loss And Credits Carryforwards
DeferredTaxAssetsOperatingLossAndCreditsCarryforwards
12978000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
409000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions
985000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies
2593000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
1867000 USD
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
20302000 USD
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
-1249000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
19053000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
4242000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
70000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
238000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
4550000 USD
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
14503000 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
45000 USD
CY2014Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
1416000 USD
CY2014Q4 hbio Deferred Tax Assets Operating Loss And Credits Carryforwards
DeferredTaxAssetsOperatingLossAndCreditsCarryforwards
12803000 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
188000 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions
889000 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies
2806000 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
1832000 USD
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
19979000 USD
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
-2423000 USD
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
17556000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
6021000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
27000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
383000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
6431000 USD
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
11125000 USD
CY2012 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0 USD
CY2011Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
191000 USD
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0 USD
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
59000 USD
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
250000 USD
CY2013Q4 us-gaap Shares Issued
SharesIssued
39385000 shares
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25771000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14134000 USD
CY2013Q4 hbio Total Indefinite Lived Intangible Assets Including Goodwill
TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill
37894000 USD
CY2013Q4 hbio Total Intangible Assets
TotalIntangibleAssets
79634000 USD
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2117000 USD
CY2012 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
192000 USD
CY2012 hbio Shares Withheld For Taxes Value
SharesWithheldForTaxesValue
145000 USD
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2160000 USD
CY2012 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
648000 shares
CY2012 us-gaap Stockholders Equity Other Shares
StockholdersEquityOtherShares
164000 shares
CY2012 hbio Shares Withheld For Taxes
SharesWithheldForTaxes
37000 shares
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
94485000 USD
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
695000 shares
CY2014 us-gaap Stockholders Equity Other Shares
StockholdersEquityOtherShares
233000 shares
CY2014 hbio Shares Withheld For Taxes
SharesWithheldForTaxes
62000 shares
CY2013 hbio Business Acquisition Direct Acquisition Costs In Income Statement
BusinessAcquisitionDirectAcquisitionCostsInIncomeStatement
0 USD
CY2012 hbio Business Acquisition Direct Acquisition Costs In Income Statement
BusinessAcquisitionDirectAcquisitionCostsInIncomeStatement
300000 USD
CY2014 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
228000 USD
CY2014 hbio Shares Withheld For Taxes Value
SharesWithheldForTaxesValue
327000 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
95499000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
104213000 USD
CY2012 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-248000 USD
CY2014 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
0 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
95468000 USD
CY2011Q4 us-gaap Shares Issued
SharesIssued
36289000 shares
CY2012Q4 us-gaap Shares Issued
SharesIssued
37124000 shares
CY2014Q4 us-gaap Shares Issued
SharesIssued
40309000 shares
CY2014 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
0 USD
CY2013 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
288000 USD
CY2012 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
314000 USD
CY2013 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
797000 USD
CY2012 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
819000 USD
CY2014 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
649000 USD
CY2013 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
524000 USD
CY2012 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
570000 USD
CY2014 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-259000 USD
CY2013 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-305000 USD
CY2013 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
197000 USD
CY2012 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
0 USD
CY2014 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
503000 USD
CY2013 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
669000 USD
CY2012 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
811000 USD
CY2013 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-329000 USD
CY2013 hbio Service Cost For Defined Benefit Plan
ServiceCostForDefinedBenefitPlan
272000 USD
CY2013 us-gaap Defined Benefit Plan Foreign Currency Exchange Rate Changes Benefit Obligation
DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
395000 USD
CY2013 us-gaap Defined Benefit Plan Benefits Paid
DefinedBenefitPlanBenefitsPaid
-431000 USD
CY2013 us-gaap Defined Benefit Plan Contributions By Plan Participants
DefinedBenefitPlanContributionsByPlanParticipants
56000 USD
CY2013 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
801000 USD
CY2014 us-gaap Defined Benefit Plan Contributions By Plan Participants
DefinedBenefitPlanContributionsByPlanParticipants
5000 USD
CY2014 us-gaap Defined Benefit Plan Benefits Paid
DefinedBenefitPlanBenefitsPaid
-457000 USD
CY2014 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
893000 USD
CY2014 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
1628000 USD
CY2014 us-gaap Defined Benefit Plan Actual Return On Plan Assets
DefinedBenefitPlanActualReturnOnPlanAssets
1119000 USD
CY2014 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
1546000 USD
CY2012Q4 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
13704000 USD
CY2013Q4 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
15540000 USD
CY2014Q4 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
16724000 USD
CY2012Q4 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
19643000 USD
CY2014Q4 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
21170000 USD
CY2013Q4 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
20403000 USD
CY2014Q4 us-gaap Defined Benefit Plan Funded Status Of Plan
DefinedBenefitPlanFundedStatusOfPlan
-4446000 USD
CY2014Q4 hbio Deferred Income Taxes On Pension Liabilities
DeferredIncomeTaxesOnPensionLiabilities
889000 USD
CY2014Q4 us-gaap Defined Benefit Pension Plan Current And Noncurrent Liabilities
DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities
4446000 USD
CY2014Q4 us-gaap Defined Benefit Plan Amounts Recognized In Balance Sheet
DefinedBenefitPlanAmountsRecognizedInBalanceSheet
-3557000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4863000 USD
CY2013 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
1909000 USD
CY2013 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-310000 USD
CY2014 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-5926000 USD
CY2014 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-337000 USD
CY2012 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-191000 USD
CY2012 us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
-77000 USD
CY2012 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
-31000 USD
CY2014Q4 us-gaap Noncurrent Assets
NoncurrentAssets
26343000 USD
CY2013Q4 us-gaap Noncurrent Assets
NoncurrentAssets
23384000 USD
CY2014Q4 hbio Segment Reporting Information Net Assets1
SegmentReportingInformationNetAssets1
95468000 USD
CY2013Q4 hbio Segment Reporting Information Net Assets1
SegmentReportingInformationNetAssets1
94485000 USD
CY2012 hbio Valuation Allowances And Reserves Currency Translation
ValuationAllowancesAndReservesCurrencyTranslation
0 USD
CY2013 hbio Valuation Allowances And Reserves Currency Translation
ValuationAllowancesAndReservesCurrencyTranslation
0 USD
CY2014 hbio Valuation Allowances And Reserves Currency Translation
ValuationAllowancesAndReservesCurrencyTranslation
-19000 USD
CY2011Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
302000 USD
CY2012Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
194000 USD
CY2012 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
214000 USD
CY2012 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
-136000 USD
CY2014 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
-102000 USD
CY2014 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
49000 USD
CY2011Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
144000 USD
CY2014Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
252000 USD
CY2014 hbio Business Acquisition Direct Acquisition Costs In Income Statement
BusinessAcquisitionDirectAcquisitionCostsInIncomeStatement
1100000 USD
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1700000 USD
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1300000 USD
CY2012 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1300000 USD
CY2014Q1 us-gaap Revenues
Revenues
25893000 USD
CY2014Q2 us-gaap Revenues
Revenues
26958000 USD
CY2014Q4 us-gaap Revenues
Revenues
30364000 USD
CY2014Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14132000 USD
CY2014Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14680000 USD
CY2014Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
16501000 USD
CY2014Q2 us-gaap Gross Profit
GrossProfit
12278000 USD
CY2014Q4 us-gaap Gross Profit
GrossProfit
13863000 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
10427000 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
10540000 USD
CY2014Q4 us-gaap Operating Expenses
OperatingExpenses
11742000 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1334000 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1738000 USD
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
2121000 USD
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-315000 USD
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-468000 USD
CY2014Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-949000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1019000 USD
CY2014Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1191000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
719000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1270000 USD
CY2014Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1172000 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
1022000 USD
CY2014Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-19000 USD
CY2014Q1 us-gaap Discontinued Operation Amount Of Other Income Loss From Disposition Of Discontinued Operation Net Of Tax
DiscontinuedOperationAmountOfOtherIncomeLossFromDispositionOfDiscontinuedOperationNetOfTax
0 USD
CY2014Q4 us-gaap Discontinued Operation Amount Of Other Income Loss From Disposition Of Discontinued Operation Net Of Tax
DiscontinuedOperationAmountOfOtherIncomeLossFromDispositionOfDiscontinuedOperationNetOfTax
0 USD
CY2014Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2014Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2014Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2014Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2014Q2 us-gaap Discontinued Operation Amount Of Other Income Loss From Disposition Of Discontinued Operation Net Of Tax
DiscontinuedOperationAmountOfOtherIncomeLossFromDispositionOfDiscontinuedOperationNetOfTax
0 USD
CY2014Q3 us-gaap Discontinued Operation Amount Of Other Income Loss From Disposition Of Discontinued Operation Net Of Tax
DiscontinuedOperationAmountOfOtherIncomeLossFromDispositionOfDiscontinuedOperationNetOfTax
0 USD
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-19000 USD
CY2014Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2014Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2014Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
719000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1022000 USD
CY2013Q4 us-gaap Operating Expenses
OperatingExpenses
12997000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1326000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
746000 USD
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-949000 USD
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-95000 USD
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-330000 USD
CY2013Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-319000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1231000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.02
CY2014Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.03
CY2014Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0
CY2014Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.02
CY2014Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.03
CY2014Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2014Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2013Q1 us-gaap Revenues
Revenues
26086000 USD
CY2013Q2 us-gaap Revenues
Revenues
26094000 USD
CY2013Q4 us-gaap Revenues
Revenues
27854000 USD
CY2013Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13826000 USD
CY2013Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14005000 USD
CY2013Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15806000 USD
CY2013Q1 us-gaap Gross Profit
GrossProfit
12260000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
12089000 USD
CY2013Q4 us-gaap Gross Profit
GrossProfit
12048000 USD
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
10934000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
11343000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
416000 USD
CY2013Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1268000 USD
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
299000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
321000 USD
CY2013Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1013000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
96000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-186000 USD
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-756000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
932000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
95000 USD
CY2013Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-255000 USD
CY2013Q1 us-gaap Discontinued Operation Amount Of Other Income Loss From Disposition Of Discontinued Operation Net Of Tax
DiscontinuedOperationAmountOfOtherIncomeLossFromDispositionOfDiscontinuedOperationNetOfTax
-836000 USD
CY2013Q2 us-gaap Discontinued Operation Amount Of Other Income Loss From Disposition Of Discontinued Operation Net Of Tax
DiscontinuedOperationAmountOfOtherIncomeLossFromDispositionOfDiscontinuedOperationNetOfTax
-281000 USD
CY2013Q3 us-gaap Discontinued Operation Amount Of Other Income Loss From Disposition Of Discontinued Operation Net Of Tax
DiscontinuedOperationAmountOfOtherIncomeLossFromDispositionOfDiscontinuedOperationNetOfTax
-935000 USD
CY2013Q4 us-gaap Discontinued Operation Amount Of Other Income Loss From Disposition Of Discontinued Operation Net Of Tax
DiscontinuedOperationAmountOfOtherIncomeLossFromDispositionOfDiscontinuedOperationNetOfTax
-501000 USD
CY2013 us-gaap Discontinued Operation Amount Of Other Income Loss From Disposition Of Discontinued Operation Net Of Tax
DiscontinuedOperationAmountOfOtherIncomeLossFromDispositionOfDiscontinuedOperationNetOfTax
-2553000 USD
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.03
CY2013Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2013Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.03
CY2013Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2013Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2013Q4 us-gaap Defined Benefit Plan Accumulated Benefit Obligation
DefinedBenefitPlanAccumulatedBenefitObligation
19500000 USD
CY2014 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
500000 USD
CY2013 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
600000 USD
CY2012 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
500000 USD
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2013Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.03
CY2013Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0
CY2013Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.01
CY2013Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.03
CY2013Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0
CY2013Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.01
CY2014Q2 dei Entity Public Float
EntityPublicFloat
138270478 USD
CY2014Q2 hbio Non Affiliate Share Holding
NonAffiliateShareHolding
30389116 shares
CY2014Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
121000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
0 USD
CY2014 hbio Minimun Percentage Of Term Loan And Delayed Draw Term Loan On Which Interest Rate Required To Be Fixed
MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed
0.5 pure
CY2013 us-gaap Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion
DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
-67000 USD
CY2013 us-gaap Derivative Instruments Loss Recognized In Other Comprehensive Income Effective Portion
DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion
-116000 USD
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2014Q4 hbio Net Operating Loss Carryforward Federal And State
NetOperatingLossCarryforwardFederalAndState
25400000 USD
CY2014Q4 hbio Net Operating Loss Carryforward Foreign
NetOperatingLossCarryforwardForeign
4900000 USD
CY2014Q4 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
5200000 USD
CY2014Q4 hbio Net Operating Loss Carryforwards Subject To Annual Limitation
NetOperatingLossCarryforwardsSubjectToAnnualLimitation
5500000 USD
CY2014Q4 hbio Net Operating Loss Carryforwards Annual Limitation
NetOperatingLossCarryforwardsAnnualLimitation
700000 USD
CY2014Q4 hbio Cash In Foreign Subsidiaries
CashInForeignSubsidiaries
12700000 USD
CY2013Q4 hbio Cash In Foreign Subsidiaries
CashInForeignSubsidiaries
23600000 USD
CY2014Q4 hbio Undistributed Foreign Earnings
UndistributedForeignEarnings
51900000 USD
CY2013Q4 hbio Undistributed Foreign Earnings
UndistributedForeignEarnings
49200000 USD
CY2012Q4 hbio Undistributed Foreign Earnings
UndistributedForeignEarnings
46000000 USD
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1300000 USD
CY2014Q4 hbio Cash Held In Foreign Subsidiaries Used For Foreign Capital Improvements
CashHeldInForeignSubsidiariesUsedForForeignCapitalImprovements
400000 USD
CY2014Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months
DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
500000 USD
CY2014Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Two
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
800000 USD
CY2014Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Three
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
600000 USD
CY2014 hbio Defined Benefit Plan Increase Decrease In Discount Rate Percentage
DefinedBenefitPlanIncreaseDecreaseInDiscountRatePercentage
0.001 pure
CY2014 hbio Defined Benefit Plan Average Pension Plan Liability
DefinedBenefitPlanAveragePensionPlanLiability
P15Y
CY2014Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter
DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
4700000 USD
CY2014 us-gaap Defined Benefit Plans Estimated Future Employer Contributions In Next Fiscal Year
DefinedBenefitPlansEstimatedFutureEmployerContributionsInNextFiscalYear
800000 USD
CY2014Q4 us-gaap Defined Benefit Plan Accumulated Benefit Obligation
DefinedBenefitPlanAccumulatedBenefitObligation
21200000 USD
CY2014Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Four
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
600000 USD
CY2014Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Five
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
700000 USD
CY2014 hbio Defined Benefit Plan Increase Decrease In Discount Rate Value
DefinedBenefitPlanIncreaseDecreaseInDiscountRateValue
89000 USD
CY2014 hbio Defined Benefit Plan Increase Decrease In Asset Return Value
DefinedBenefitPlanIncreaseDecreaseInAssetReturnValue
17000 USD
CY2014 hbio Defined Benefit Plan Increase Decrease In Asset Return Percentage
DefinedBenefitPlanIncreaseDecreaseInAssetReturnPercentage
0.001 pure
CY2014 hbio Defined Benefit Plan Average Remaining Work Lifetime
DefinedBenefitPlanAverageRemainingWorkLifetime
P15Y
CY2014 hbio Fair Value Impairment Of Pension Assets
FairValueImpairmentOfPensionAssets
600000 USD
CY2014 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
57848 shares
CY2013 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
56938 shares
CY2012 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
60028 shares
CY1996Q4 hbio Shares Authorized For Issuance Under1996 Stock Option And Incentive Plan
SharesAuthorizedForIssuanceUnder1996StockOptionAndIncentivePlan
4072480 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
15008929 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
13067675 shares
CY2014Q4 hbio Limitation Of Number Of Awards That Can Be Issued Under Stock Option And Incentive Plan
LimitationOfNumberOfAwardsThatCanBeIssuedUnderStockOptionAndIncentivePlan
3750000 shares
CY2014Q4 hbio Increase In Number Of Shares Authorized For Issuance Under Stock Option And Incentive Plan
IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan
3700000 shares
CY2014 hbio Fungible Shares Issuance Ratio
FungibleSharesIssuanceRatio
1.79 pure
CY2014Q4 hbio Incentive Stock Options Granted To Date
IncentiveStockOptionsGrantedToDate
10218057 shares
CY2013Q4 hbio Incentive Stock Options Granted To Date
IncentiveStockOptionsGrantedToDate
10218057 shares
CY2012Q4 hbio Incentive Stock Options Granted To Date
IncentiveStockOptionsGrantedToDate
8990395 shares
CY2014Q4 hbio Non Qualified Stock Options Granted To Date
NonQualifiedStockOptionsGrantedToDate
12143374 shares
CY2013Q4 hbio Non Qualified Stock Options Granted To Date
NonQualifiedStockOptionsGrantedToDate
11028074 shares
CY2012Q4 hbio Non Qualified Stock Options Granted To Date
NonQualifiedStockOptionsGrantedToDate
8906684 shares
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2547580 shares
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4700033 shares
CY2013Q4 hbio Incremental Options Granted Due To Hart Spinoff
IncrementalOptionsGrantedDueToHartSpinoff
1715164 shares
CY2013Q4 hbio Incremental Units Granted Due To Hart Spinoff
IncrementalUnitsGrantedDueToHartSpinoff
135650 shares
CY2014Q4 hbio In The Money Stock Options Exercisable At The Reporting Date
InTheMoneyStockOptionsExercisableAtTheReportingDate
3419917 shares
CY2014Q4 hbio Common Stock Market Value Per Share On Reporting Date
CommonStockMarketValuePerShareOnReportingDate
5.67
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1800000 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
5100000 USD
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
300000 USD
CY2014Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3500000 USD
CY2014 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M4D
CY2014 hbio Annualized Estimated Forfeiture Rate
AnnualizedEstimatedForfeitureRate
0.0705 pure
CY2013 hbio Annualized Estimated Forfeiture Rate
AnnualizedEstimatedForfeitureRate
0.0654 pure
CY2012 hbio Annualized Estimated Forfeiture Rate
AnnualizedEstimatedForfeitureRate
0.0538 pure
CY2014 hbio Weighted Average Estimated Black Scholes Value Of Option Grants
WeightedAverageEstimatedBlackScholesValueOfOptionGrants
2.18
CY2013 hbio Weighted Average Estimated Black Scholes Value Of Option Grants
WeightedAverageEstimatedBlackScholesValueOfOptionGrants
2.41
CY2012 hbio Weighted Average Estimated Black Scholes Value Of Option Grants
WeightedAverageEstimatedBlackScholesValueOfOptionGrants
1.84
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
3321000 USD
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32170683 shares
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30384010 shares
CY2012 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28799377 shares
CY2014 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1065886 shares
CY2013 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1529789 shares
CY2012 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
992730 shares
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33236569 shares
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31913799 shares
CY2012 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29792107 shares
CY2014 dei Trading Symbol
TradingSymbol
HBIO
CY2014 us-gaap Defined Benefit Plan Foreign Currency Exchange Rate Changes Benefit Obligation
DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
-1302000 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3349052 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1220934 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
-1326233 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
-1014000 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
259931 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
-281650 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
-164090 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
-191501 shares
CY2012 hbio Stock Issued During Period Gross Stock Options Exercised
StockIssuedDuringPeriodGrossStockOptionsExercised
648000 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
349295 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.44
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
-47462 shares
CY2013 hbio Stock Issued During Period Gross Stock Options Exercised
StockIssuedDuringPeriodGrossStockOptionsExercised
3410483 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.6
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
5.26
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
6.36
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.62
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.57
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.2
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.94
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
4.07
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
4.21
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
3.97
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.32
CY2012Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
4.25
CY2011Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
4.52
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8078509 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8519575 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
677193 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
539450 shares

Files In Submission

Name View Source Status
0001171843-15-001376-index-headers.html Edgar Link pending
0001171843-15-001376-index.html Edgar Link pending
0001171843-15-001376.txt Edgar Link pending
0001171843-15-001376-xbrl.zip Edgar Link pending
exh_1020.htm Edgar Link pending
exh_211.htm Edgar Link pending
exh_231.htm Edgar Link pending
exh_24.htm Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
exh_322.htm Edgar Link pending
f10k_031215.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
graph.jpg Edgar Link pending
hbio-20141231.xml Edgar Link completed
hbio-20141231.xsd Edgar Link pending
hbio-20141231_cal.xml Edgar Link unprocessable
hbio-20141231_def.xml Edgar Link unprocessable
hbio-20141231_lab.xml Edgar Link unprocessable
hbio-20141231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending